medigraphic.com
ISSN 1684-1824 (Electronic)

2020, Number 4

Next >>

Rev Méd Electrón 2020; 42 (4)

Treatment trombolitico in the sharp coronary syndrome with elevation of the st

Verónica ÁM, Denis PA

Language: Spanish
References: 18
Page:
PDF size: 130.37 Kb.


ABSTRACT

Introduction: The Ischemic Cardiopatía is as old as the man. One constitutes from the most serious problems of health to world level and enter their clinical forms the sharp heart attack of miocardio is (IMA), causing in the world population a third of the deaths. The sharp ischemic syndromes SIAs represents a continuous clinical spectrum sustained by a fisiopatología común.
Objective: He/she was carried out an observational, descriptive and traverse study, in 62 patients with trombolisis approach assisted in the UCIE of the Surgical Clinical Educational Hospital José Ramón López Tabrane, in the period understood between January of 2012 and June of the 2014.Se they applied the empiric, statistical and theoretical methods.
Materials and method: identify the factors that caused delay in the application of the treatment trombolítico in this patients, which are translated in the future in loss of quality of life, different discapacidad grades and until of the increase of the mortality for this entity. Among the causes that were they were: the non training of the doctors for the application of this treatment and the not existence of transport for their transfer in the required time.
Conclusion: In patient non trombolizados with more than twelve hours without diagnostic of IMA (19,4%) with approach impacted the doctor's erroneous diagnosis and valency of their own means to arrive to a center of health. With absolute contraindication, the Ischemic Vascular Accident smaller than three months was the causing one more suffered. With relative contraindication it was the arterial hypertension not controlled.


REFERENCES

  1. Lovesio C. Medicina Intensiva [Internet]. 6ta ed. Argentina; 2017[citado 12/10/2019]. Disponible en: Disponible en: https://www.edicionesjournal.com/Papel/9789871860364/Medicina+Intensiva+Ed+7%C2%BA

  2. MINSAP. Anuario Estadístico de Salud. La Habana: MINSAP; 2018[citado 12/10/2019]. Disponible en: Disponible en: https://salud.msp.gob.cu/?p=1530

  3. Barrabésa JA, Bardajíb A, Jiménez-Candilc J. Pronóstico y manejo del síndrome coronario agudo en España en 2012: estudio DIOCLES. REC[Internet]. 2015[citado 12/10/2019]; 68 (2) :85-6. Disponible en: Disponible en: https://www.revespcardiol.org/es-pronostico-manejo-del-sindrome-coronario-articulo-S0300893214002565

  4. González Rodríguez R, Carrillo Blanco Y, Barcón Díaz L, Vilaú Díaz JL, et al. Efectividad de la trombolisis en el infarto agudo del miocardio en hospital Abel Santamaría Cuadrado. Rev Ciencias Médicas Pinar del Río [Internet].2019 [citado 22/10/2019]; 23 (2) Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942019000200224

  5. Borda-Velásquez L, Razzeto-Rubio L, Rey-Mendoza J, et al. Estrategias de reperfusión usadas en pacientes con síndrome coronario agudo con elevación persistente del segmento ST en un hospital general. Rev Med Hered [Internet]. 2015 [citado 20/04/2018]; 26(1): [aprox. 6p.]. Disponible en:Disponible en:http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1018-130X2015000100007&lng=es

  6. Llancaqueo M, Moreno Molinero A. Manejo del síndrome coronario agudo en el paciente adulto mayor. Rev Médica Clínica Las Condes[Internet]. 2017[citado 20/04/2018];28(2).Disponible en: Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-manejo-del-sindrome-coronario-agudo-S0716864017300457

  7. Coll-Muñoz Y, Valladares-Carvajal F, González-Rodríguez C. Infarto agudo de miocardio. Actualización de la Guía de Práctica Clínica. Rev Finlay [Internet]. 2016 [citado 20/04/2018]; 6(2): [aprox. 20 p.]. Disponible en: Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/403

  8. Olivera Escalona AL. Reperfusión coronaria en el infarto agudo del miocardio con elevación del segmento ST: importancia del contexto y tiempo de aplicación. MEDISAN [Internet]. 2015 [citado 20/04/2018]; 19(10). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015001000011&lng=es

  9. Rhudy JP, Bakitas MA, Hyrkäs K, et al Effectiveness of regionalized systems for stroke and myocardial infarction. Brain and Behavior. 2015; 5(10). Citado en PubMed; PMID: 26516616.

  10. Langabeer JR, Smith DT, Cardenas-Turanzas M, et al . Impact of a Rural Regional Myocardial Infarction System of Care in Wyoming. J Am Heart Assoc. 2016 ;5(5). Citado en PubMed; PMID: 27207968.

  11. Mega JL, MorrowIn DA. ST-elevation myocardial infarction: management. In: MannD, Zipes D, Libby P, Bonow R. Braunwald's heart disease: a textbook of cardiovascular medicine[Internet].10th ed. Philadelphia: Elsevier; 2015[citado 20/04/2018]. p. 1095-147 . Disponible en: Disponible en: https://www.elsevier.com/books/braunwalds-heart-disease-a-textbook-of-cardiovascular-medicine-single-volume/mann/978-1-4557-5134-1

  12. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018 ;39(2):119-177. Citado en PubMed; PMID:28886621

  13. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016 ;37(3):267-315. Citado en PubMed; PMID: 26320110.

  14. Roffi M, Patrono C, Collet JP, et al. 2015 sobre el tratamiento de los sindromes coronarios agudos en pacientes sin elevacion persistente del segmento ST. Rev Esp Cardiol[Internet]. 2015;68(12):1061-67. Disponible en: https://www.revespcardiol.org/es-guia-esc-2015-sobre-el-articulo-S0300893215005928?redirect=true

  15. Sanchis J, Abellán L, García-Blas S, et al. Usefulness of delta troponin for diagnosis and prognosis assessment of non-ST-segment elevation acute chest pain. Eur Heart J Acute Cardiovasc Care. 2016 [citado 20/04/2018];5(5):399-406. Citado en PubMed; PMID: 26136512.

  16. Niccoli G, Montone RA, Di Vito L, et al. Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome. Eur Heart J. 2015;36(22):1377-84. Citado en PubMed; PMID: 25713314.

  17. Layland J, Oldroyd KG, Curzen N, et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J . 2015; 36:100-11. Citado en PubMed; PMID: 25179764.

  18. Finn M, Green P. Influencia de la fragilidad del paciente en las enfermedades cardiovasculares. Rev Esp Cardiol[Internet]. 2015[citado 20/04/2018];68(8):653-6. Disponible en: Disponible en: https://www.revespcardiol.org/en-influencia-fragilidad-del-paciente-las-articulo-S0300893215002882




2020     |     www.medigraphic.com